Sign in
SCHEDULE 13G/A

Statement of Beneficial Ownership

Cytek Biosciences, Inc. Filed Acc 0001386060-26-000063

Stakes reported in this filing

Reporting person Shares Of the class
Boston Partners 8,002,638 6.16%

Members of a group can each report the same shares, so these rows overlap and don't add up.

Loading xslSCHEDULE_13G_X02/primary_doc.xml…